http://www.clinicaltrials.gov/ct2/show/NCT00528528?term=telaprevir&rank=2 This is pretty close to the study I will be in with the primary difference is that there will be 500 non-naive patients WORLD WIDE - 6 in my group, with only 3 of us non-responders. The other 3 are considered relapsers, those who cleared and detectable viral levels have
(
Read more... )
It's possible that they are implementing a kind of failsafe arm on the trial. They do that a lot with oncology products - usually they will conduct the randomization at baseline, and then at some predetermined time afterward, assess the progress of patients on placebo vs. investigational product. The reason being, if you have significant benefit shown on the investigational arm, it would be unethical to deny that benefit to the placebo patients - patients would at that failsafe point, be permitted to switch arms.
I'm making you a little cabled alpaca wrap - remembered you were always cold during your last tx cycle.
Reply
The wrap sounds fantastic :) I was reviewing some notes from the first go-round with combo and have located all things warm and snuggly for the chills, and all things fibery for the, well, the other ongoing problem =p I also plan to stock up on Ensure since that was about the only thing I could hold down for a while.
Am trying to think positive - at least I can prepare somewhat, knowing a bit what to expect.
Reply
Leave a comment